Analysis of MT1-MMP and MMP2 expression in human gastric cancers

Masaki Mori, Koshi Mimori, Takeshi Shiraishi, Tatsuo Fujie, Kinya Baba, Hiroki Kusumoto, Masaru Haraguchi, Hiroaki Ueo, Tsuyoshi Akiyoshi

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N ratio) of MT1-MMP expression was determined by reverse transcription- polymerase chain reaction analysis. To visualize the localization of MT1- MMP, an immunohistochemical study was performed. In addition, a gelatin zymography was done to examine the activation ratio of MMP2, and a correlation between MT1-MMP expression and activation of MMP2 was studied. The expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue in most cases. The mean value of the T/N ratio was 4.8. Twenty cases with T/N ≤ 4.8 showed significantly deeper invasion and higher frequency of lymph node metastasis than 48 cases with T/N < 4,8. MT1-MMP expression was an independent factor influencing both tumor invasion of the gastric wall and lymph node metastasis. Although MT1-MMP expression was not an independent prognostic factor, the patients with T/N ≤ 4.8 showed a significantly worse prognosis than those with T/N < 4.8. An immunohistochemical study demonstrated that MT1-MMP expression was mainly recognized in the tumor cells. There was a significant correlation between MT1-MMP expression and activation of MMP2. Our findings suggest that: 1) the expression of MT1-MMP may influence prognosis via tumor invasion of the gastric wall and lymph node metastasis, and 2) MT1-MMP activation of MMP2 may be clinically relevant in gastric carcinoma tumors.

Original languageEnglish
Pages (from-to)316-321
Number of pages6
JournalInternational Journal of Cancer
Volume74
Issue number3
DOIs
Publication statusPublished - Aug 13 1997

Fingerprint

Matrix Metalloproteinase 14
Stomach Neoplasms
Neoplasms
Stomach
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Gelatin
Reverse Transcription

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Analysis of MT1-MMP and MMP2 expression in human gastric cancers. / Mori, Masaki; Mimori, Koshi; Shiraishi, Takeshi; Fujie, Tatsuo; Baba, Kinya; Kusumoto, Hiroki; Haraguchi, Masaru; Ueo, Hiroaki; Akiyoshi, Tsuyoshi.

In: International Journal of Cancer, Vol. 74, No. 3, 13.08.1997, p. 316-321.

Research output: Contribution to journalArticle

Mori, Masaki ; Mimori, Koshi ; Shiraishi, Takeshi ; Fujie, Tatsuo ; Baba, Kinya ; Kusumoto, Hiroki ; Haraguchi, Masaru ; Ueo, Hiroaki ; Akiyoshi, Tsuyoshi. / Analysis of MT1-MMP and MMP2 expression in human gastric cancers. In: International Journal of Cancer. 1997 ; Vol. 74, No. 3. pp. 316-321.
@article{da42b99706f041aca0aeea0485c92874,
title = "Analysis of MT1-MMP and MMP2 expression in human gastric cancers",
abstract = "Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N ratio) of MT1-MMP expression was determined by reverse transcription- polymerase chain reaction analysis. To visualize the localization of MT1- MMP, an immunohistochemical study was performed. In addition, a gelatin zymography was done to examine the activation ratio of MMP2, and a correlation between MT1-MMP expression and activation of MMP2 was studied. The expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue in most cases. The mean value of the T/N ratio was 4.8. Twenty cases with T/N ≤ 4.8 showed significantly deeper invasion and higher frequency of lymph node metastasis than 48 cases with T/N < 4,8. MT1-MMP expression was an independent factor influencing both tumor invasion of the gastric wall and lymph node metastasis. Although MT1-MMP expression was not an independent prognostic factor, the patients with T/N ≤ 4.8 showed a significantly worse prognosis than those with T/N < 4.8. An immunohistochemical study demonstrated that MT1-MMP expression was mainly recognized in the tumor cells. There was a significant correlation between MT1-MMP expression and activation of MMP2. Our findings suggest that: 1) the expression of MT1-MMP may influence prognosis via tumor invasion of the gastric wall and lymph node metastasis, and 2) MT1-MMP activation of MMP2 may be clinically relevant in gastric carcinoma tumors.",
author = "Masaki Mori and Koshi Mimori and Takeshi Shiraishi and Tatsuo Fujie and Kinya Baba and Hiroki Kusumoto and Masaru Haraguchi and Hiroaki Ueo and Tsuyoshi Akiyoshi",
year = "1997",
month = "8",
day = "13",
doi = "10.1002/(SICI)1097-0215(19970620)74:3<316::AID-IJC14>3.0.CO;2-9",
language = "English",
volume = "74",
pages = "316--321",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Analysis of MT1-MMP and MMP2 expression in human gastric cancers

AU - Mori, Masaki

AU - Mimori, Koshi

AU - Shiraishi, Takeshi

AU - Fujie, Tatsuo

AU - Baba, Kinya

AU - Kusumoto, Hiroki

AU - Haraguchi, Masaru

AU - Ueo, Hiroaki

AU - Akiyoshi, Tsuyoshi

PY - 1997/8/13

Y1 - 1997/8/13

N2 - Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N ratio) of MT1-MMP expression was determined by reverse transcription- polymerase chain reaction analysis. To visualize the localization of MT1- MMP, an immunohistochemical study was performed. In addition, a gelatin zymography was done to examine the activation ratio of MMP2, and a correlation between MT1-MMP expression and activation of MMP2 was studied. The expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue in most cases. The mean value of the T/N ratio was 4.8. Twenty cases with T/N ≤ 4.8 showed significantly deeper invasion and higher frequency of lymph node metastasis than 48 cases with T/N < 4,8. MT1-MMP expression was an independent factor influencing both tumor invasion of the gastric wall and lymph node metastasis. Although MT1-MMP expression was not an independent prognostic factor, the patients with T/N ≤ 4.8 showed a significantly worse prognosis than those with T/N < 4.8. An immunohistochemical study demonstrated that MT1-MMP expression was mainly recognized in the tumor cells. There was a significant correlation between MT1-MMP expression and activation of MMP2. Our findings suggest that: 1) the expression of MT1-MMP may influence prognosis via tumor invasion of the gastric wall and lymph node metastasis, and 2) MT1-MMP activation of MMP2 may be clinically relevant in gastric carcinoma tumors.

AB - Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N ratio) of MT1-MMP expression was determined by reverse transcription- polymerase chain reaction analysis. To visualize the localization of MT1- MMP, an immunohistochemical study was performed. In addition, a gelatin zymography was done to examine the activation ratio of MMP2, and a correlation between MT1-MMP expression and activation of MMP2 was studied. The expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue in most cases. The mean value of the T/N ratio was 4.8. Twenty cases with T/N ≤ 4.8 showed significantly deeper invasion and higher frequency of lymph node metastasis than 48 cases with T/N < 4,8. MT1-MMP expression was an independent factor influencing both tumor invasion of the gastric wall and lymph node metastasis. Although MT1-MMP expression was not an independent prognostic factor, the patients with T/N ≤ 4.8 showed a significantly worse prognosis than those with T/N < 4.8. An immunohistochemical study demonstrated that MT1-MMP expression was mainly recognized in the tumor cells. There was a significant correlation between MT1-MMP expression and activation of MMP2. Our findings suggest that: 1) the expression of MT1-MMP may influence prognosis via tumor invasion of the gastric wall and lymph node metastasis, and 2) MT1-MMP activation of MMP2 may be clinically relevant in gastric carcinoma tumors.

UR - http://www.scopus.com/inward/record.url?scp=0030818084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030818084&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19970620)74:3<316::AID-IJC14>3.0.CO;2-9

DO - 10.1002/(SICI)1097-0215(19970620)74:3<316::AID-IJC14>3.0.CO;2-9

M3 - Article

C2 - 9221811

AN - SCOPUS:0030818084

VL - 74

SP - 316

EP - 321

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -